| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $7,851,153 ) (Continued on the next page) |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | 2201ALPADD | PADD-2022 | 2 | 1 | ACL | 5/9/2022 | $329,451 |
| | 2022 | 2022 | University of Alabama | 301 Rose Admin Bldg | Tuscaloosa | AL | 35487-0001 | TUSCALOOSA | USA | T3442131 | Primary Care Training and Enhancement-Community Prevention and Maternal Health | 00 | 2 | HRSA | 5/12/2022 | $274,492 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | X98SM085922 | Protection & Advocacy for Individuals with Mntl Illness | 002 | 1 | SAMHSA | 5/16/2022 | $303,103 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | X98SM085922 | Protection & Advocacy for Individuals with Mntl Illness | 000 | 1 | SAMHSA | 11/29/2021 | $80,293 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | X98SM085922 | Protection & Advocacy for Individuals with Mntl Illness | 001 | 1 | SAMHSA | 1/7/2022 | $96,626 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | 2201ALPAVA | PAVA-2022 | 2 | 1 | ACL | 5/9/2022 | $75,978 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | 2201ALPAVA | PAVA-2022 | 1 | 1 | ACL | 1/26/2022 | $23,699 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | R01GM112919 | Conformational dynamics and allosteric regulation during stress-responsive metallocofactor assembly | 000 | 7 | NIH | 4/6/2022 | $268,745 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | R01EY028169 | Systemic anti-inflammatory therapy to prevent or delay diabetic cataracts and treat post-surgical inflammation | 000 | 6 | NIH | 5/16/2022 | $85,419 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | R01MD013806 | Reducing Youth Violence and Racism/Discrimination: The Efficacy of Comprehensive Prevention Strategies (CPS) | 000 | 4 | NIH | 1/18/2022 | $60,081 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | R01MD013806 | Reducing Youth Violence and Racism/Discrimination: The Efficacy of Comprehensive Prevention Strategies (CPS) | 000 | 4 | NIH | 1/18/2022 | $644,860 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | R01MD013806 | Reducing Youth Violence and Racism/Discrimination: The Efficacy of Comprehensive Prevention Strategies (CPS) | 001 | 4 | NIH | 4/27/2022 | $138,407 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | R25GM130517 | Expanding the Genomics Education Partnership: Regional Mentoring and Training Networks to Diversify Bioinformatics Education and Research | 000 | 4 | NIH | 3/24/2022 | $397,870 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | R25GM130517 | Expanding the Genomics Education Partnership: Regional Mentoring and Training Networks to Diversify Bioinformatics Education and Research | 001 | 4 | NIH | 6/14/2022 | $44,211 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | K01HL145128 | Adiposity and Sleep-Associated Cardiometabolic Disease Risk Factors | 000 | 4 | NIH | 5/23/2022 | $153,262 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | R01DK122473 | Sensor-based Just-in Time Adaptive Interventions (JITAIs) Targeting Eating Behavior | 000 | 4 | NIH | 6/7/2022 | $584,698 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | R01DK125372 | Oral delivery of insulin using ligand-directed nanoparticles that do not compete with physiological ligands | 000 | 3 | NIH | 2/28/2022 | $335,250 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | R01DK125372 | Oral delivery of insulin using ligand-directed nanoparticles that do not compete with physiological ligands | 001 | 3 | NIH | 3/24/2022 | $37,250 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | R21DC019073 | Improving Access and Affordability of Adult Hearing Healthcare: Effectiveness of Community-based Interventions in West Central and South Alabama | 000 | 2 | NIH | 2/3/2022 | $199,442 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | R21DC019073 | Improving Access and Affordability of Adult Hearing Healthcare: Effectiveness of Community-based Interventions in West Central and South Alabama | 001 | 2 | NIH | 4/22/2022 | $22,160 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | H79SM081438 | Mobile Mental Health Education, Awareness and Learning (mHEAL) Initiative for Law Enforcement | 000 | 3 | SAMHSA | 4/18/2022 | $125,000 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | R35GM142966 | Determining the specificity and regulation of Type III CRISPR-Cas interference | 000 | 2 | NIH | 6/9/2022 | $355,717 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | R01DK125692 | Targeting transient receptor potential channels to suppress proviral mitochondrial fission and mitophagy in order to mitigate CVB pancreatitis | 002 | 2 | NIH | 2/24/2022 | $0 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | R01DK125692 | Targeting transient receptor potential channels to suppress proviral mitochondrial fission and mitophagy in order to mitigate CVB pancreatitis | 001 | 2 | NIH | 2/23/2022 | $295,020 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | R01DK125692 | Targeting transient receptor potential channels to suppress proviral mitochondrial fission and mitophagy in order to mitigate CVB pancreatitis | 003 | 2 | NIH | 3/31/2022 | $32,780 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | R01DK125692 | Targeting transient receptor potential channels to suppress proviral mitochondrial fission and mitophagy in order to mitigate CVB pancreatitis | 005 | 2 | NIH | 5/6/2022 | $273,881 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | R01DK128597 | Urolithin A nanoparticle therapy for acute kidney injury | 000 | 2 | NIH | 3/25/2022 | $323,152 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | R25GM142027 | The Health Sciences & Technology Academy ? Alabama (HSTA-AL) | 000 | 2 | NIH | 4/1/2022 | $227,152 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | R25GM142027 | The Health Sciences & Technology Academy ? Alabama (HSTA-AL) | 001 | 2 | NIH | 6/13/2022 | $25,242 |
| | 2022 | 2022 | University of Alabama | 301 Rose Admin Bldg | Tuscaloosa | AL | 35487-0001 | TUSCALOOSA | USA | E0128810 | Nurse Faculty Loan Program | 00 | 7 | HRSA | 6/10/2022 | $776,565 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | K01DA054262 | Momentary Geospatial, Psychological, and Behavioral Risk for Substance Use in Young Adults Under Criminal Justice Supervision | 000 | 1 | NIH | 3/10/2022 | $161,241 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | R61NS123196 | Nanoparticles with Two-Stage Delivery of Tetrodotoxin for Prolonged Duration Local Anesthesia | 000 | 1 | NIH | 6/20/2022 | $327,675 |
| | 2022 | 2022 | University of Alabama | 301 Rose Admin Bldg | Tuscaloosa | AL | 35487-0001 | TUSCALOOSA | USA | D4033364 | Graduate Psychology Education Programs | 00 | 4 | HRSA | 5/26/2022 | $337,500 |
| | 2022 | 2022 | University of Alabama | 301 Rose Admin Bldg | Tuscaloosa | AL | 35487-0001 | TUSCALOOSA | USA | D4033364 | Graduate Psychology Education Programs | 00 | 4 | HRSA | 5/26/2022 | $112,500 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | 2201ALPAPH | PAPH-2022 | 0 | 1 | ACL | 2/23/2022 | $114,000 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | 2201ALPATB | PATB-2022 | 0 | 1 | ACL | 11/17/2021 | $9,692 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | 2201ALPATB | PATB-2022 | 1 | 1 | ACL | 1/26/2022 | $11,667 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | 2201ALPATB | PATB-2022 | 2 | 1 | ACL | 5/9/2022 | $36,485 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | 2201ALPAAT | PAAT-2022 | 0 | 1 | ACL | 11/17/2021 | $10,173 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | 2201ALPAAT | PAAT-2022 | 1 | 1 | ACL | 1/26/2022 | $12,245 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | 2201ALPAAT | PAAT-2022 | 2 | 1 | ACL | 5/9/2022 | $39,474 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | 2201ALPADD | PADD-2022 | 0 | 1 | ACL | 11/17/2021 | $89,139 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | 2201ALPADD | PADD-2022 | 1 | 1 | ACL | 1/26/2022 | $107,296 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | R01GM112919 | Conformational dynamics and allosteric regulation during stress-responsive metallocofactor assembly | 001 | 7 | NIH | 5/5/2022 | $3,841 |
| | 2022 | 2022 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | 2201ALPAVA | PAVA-2022 | 0 | 1 | ACL | 11/17/2021 | $19,688 |
| | 2022 | 2021 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | R33AT010802 | A Mindfulness and Peer Mentoring Program to Improve Adherence to Medication Assisted Treatment for Opioid Use Disorders | 000 | 2 | NIH | 2/9/2022 | $0 |
| | 2022 | 2021 | University Of Alabama | 301 Rose Admin Bldg | Tuscaloosa | AL | 35487-0001 | TUSCALOOSA | USA | CPIMP211309 | The Deep South Health Equity Project (DS-HELP): Increasing Diversity in Lupus Clinical Trials | 01 | 1 | DHHS/OS | 10/27/2021 | $0 |
| | 2022 | 2021 | University Of Alabama | 301 Rose Admin Bldg | Tuscaloosa | AL | 35487-0001 | TUSCALOOSA | USA | CPIMP211309 | The Deep South Health Equity Project (DS-HELP): Increasing Diversity in Lupus Clinical Trials | 02 | 1 | DHHS/OS | 12/29/2021 | $0 |
| | 2022 | 2021 | University of Alabama | 301 Rose Admin Bldg | Tuscaloosa | AL | 35487-0001 | TUSCALOOSA | USA | CPIMP211309 | The Deep South Health Equity Project (DS-HELP): Increasing Diversity in Lupus Clinical Trials | 03 | 1 | DHHS/OS | 6/15/2022 | $0 |
|
